BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Failure Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Is Cardiac Cell Therapy Worth Another Look? The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial. Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections indicate that the incidence of heart failure will continue to increase.[3] The unprecedented growth in cardiac failure in aging populations will challenge existing systems of care and should cause us to re...